Table 3.
Matrix effect and extraction recovery of GCDCA-S and CDCA in different matrices.
| Conc. (ng/mL) | QC Matrices | Matrix Effect | Recovery | ||
|---|---|---|---|---|---|
| Mean Matrix Effect (%) | CV (%) | Mean Recovery (%) | CV (%) | ||
| GCDCA-S | |||||
| 1.5 | Pooled mouse plasma | 111 | 10.9 | 88.8 | 9.58 |
| 90 | 115a | 11.2 | 120 | 13.6 | |
| 5 | pooled human plasma | NAb | NAb | 80.7 | 1.16 |
| 900 | 111 | 6.70 | 114 | 6.72 | |
| CDCA-24G | |||||
| 1.5 | Pooled mouse plasma | 88.0 | 8.88 | 89.8 | 7.26 |
| 90 | 109 | 8.70 | 104 | 3.78 | |
| 1.5 | pooled human plasma | NAb | NAb | 90.6 | 12.2 |
| 90 | 87.1 | 11.1 | 94.0 | 4.91 | |
The calculated mean matrix effect 114.814 was rounded to 115 as 3 significant figures kept.
The matrix effect result of prepared GCDCA-S and CDCA-24G at 5 ng/mL and 1.5 ng/mL in pooled human plasma was not available.